Microvascular Experimentation in the Chick Chorioallantoic Membrane as a Model for Screening Angiogenic Agents including from Gene-Modified Cells
- PMID: 35008876
- PMCID: PMC8745510
- DOI: 10.3390/ijms23010452
Microvascular Experimentation in the Chick Chorioallantoic Membrane as a Model for Screening Angiogenic Agents including from Gene-Modified Cells
Abstract
The chick chorioallantoic membrane (CAM) assay model of angiogenesis has been highlighted as a relatively quick, low cost and effective model for the study of pro-angiogenic and anti-angiogenic factors. The chick CAM is a highly vascularised extraembryonic membrane which functions for gas exchange, nutrient exchange and waste removal for the growing chick embryo. It is beneficial as it can function as a treatment screening tool, which bridges the gap between cell based in vitro studies and in vivo animal experimentation. In this review, we explore the benefits and drawbacks of the CAM assay to study microcirculation, by the investigation of each distinct stage of the CAM assay procedure, including cultivation techniques, treatment applications and methods of determining an angiogenic response using this assay. We detail the angiogenic effect of treatments, including drugs, metabolites, genes and cells used in conjunction with the CAM assay, while also highlighting the testing of genetically modified cells. We also present a detailed exploration of the advantages and limitations of different CAM analysis techniques, including visual assessment, histological and molecular analysis along with vascular casting methods and live blood flow observations.
Keywords: angiogenesis; blood flow; cancer; chorioallantoic membrane (CAM); microcirculation; tumour.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
The chick embryo chorioallantoic membrane (CAM) assay.Reprod Toxicol. 2017 Jun;70:97-101. doi: 10.1016/j.reprotox.2016.11.004. Epub 2016 Nov 8. Reprod Toxicol. 2017. PMID: 27832950 Review.
-
Establishment of an in ovo chick embryo yolk sac membrane (YSM) assay for pilot screening of potential angiogenic and anti-angiogenic agents.Cell Biol Int. 2018 Nov;42(11):1474-1483. doi: 10.1002/cbin.11051. Epub 2018 Sep 11. Cell Biol Int. 2018. PMID: 30136736
-
Chick embryo chorioallantoic membrane as a useful tool to study angiogenesis.Int Rev Cell Mol Biol. 2008;270:181-224. doi: 10.1016/S1937-6448(08)01405-6. Int Rev Cell Mol Biol. 2008. PMID: 19081537 Review.
-
The chick embryo chorioallantoic membrane (CAM). A multifaceted experimental model.Mech Dev. 2016 Aug;141:70-77. doi: 10.1016/j.mod.2016.05.003. Epub 2016 May 10. Mech Dev. 2016. PMID: 27178379 Review.
-
The use of the chick embryo CAM assay in the study of angiogenic activiy of biomaterials.Microvasc Res. 2020 Sep;131:104026. doi: 10.1016/j.mvr.2020.104026. Epub 2020 Jun 5. Microvasc Res. 2020. PMID: 32505611 Review.
Cited by
-
Deciphering the Precise Target for Saroglitazar Associated Antiangiogenic Effect: A Computational Synergistic Approach.ACS Omega. 2023 Apr 20;8(17):14985-15002. doi: 10.1021/acsomega.2c07570. eCollection 2023 May 2. ACS Omega. 2023. PMID: 37151537 Free PMC article.
-
A Novel Artificial Intelligence-Based Approach for Quantitative Assessment of Angiogenesis in the Ex Ovo CAM Model.Cancers (Basel). 2022 Sep 1;14(17):4273. doi: 10.3390/cancers14174273. Cancers (Basel). 2022. PMID: 36077809 Free PMC article.
-
Amniotic membrane promotes doxorubicin potency by suppressing SH-SY5Y neuroblastoma cell angiogenesis.BMC Cancer. 2025 Jun 19;25(1):1021. doi: 10.1186/s12885-025-14442-z. BMC Cancer. 2025. PMID: 40537738 Free PMC article.
-
Development of Solid Nanosystem for Delivery of Chlorhexidine with Increased Antimicrobial Activity and Decreased Cytotoxicity: Characterization and In Vitro and In Ovo Toxicological Screening.Molecules. 2025 Jan 3;30(1):162. doi: 10.3390/molecules30010162. Molecules. 2025. PMID: 39795218 Free PMC article.
-
Standardization to Characterize the Complexity of Vessel Network Using the Aortic Ring Model.Int J Mol Sci. 2024 Dec 31;26(1):291. doi: 10.3390/ijms26010291. Int J Mol Sci. 2024. PMID: 39796147 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous